These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9464679)

  • 1. Alzheimer's disease: a re-examination of the amyloid hypothesis.
    Neve RL; Robakis NK
    Trends Neurosci; 1998 Jan; 21(1):15-9. PubMed ID: 9464679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiology and pathogenesis of Alzheimer dementia].
    Kratzsch T; Peters J; Frölich L
    Wien Med Wochenschr; 2002; 152(3-4):72-6. PubMed ID: 11925775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.
    Rocchi A; Orsucci D; Tognoni G; Ceravolo R; Siciliano G
    Curr Alzheimer Res; 2009 Jun; 6(3):224-37. PubMed ID: 19519304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
    He SR; Liu DG; Wang S; Xia YJ
    Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
    Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
    Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
    Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
    Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
    Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway.
    Lippa CF; Saunders AM; Smith TW; Swearer JM; Drachman DA; Ghetti B; Nee L; Pulaski-Salo D; Dickson D; Robitaille Y; Bergeron C; Crain B; Benson MD; Farlow M; Hyman BT; George-Hyslop SP; Roses AD; Pollen DA
    Neurology; 1996 Feb; 46(2):406-12. PubMed ID: 8614503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
    Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
    Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.
    Kumar NT; Liestøl K; Løberg EM; Reims HM; Mæhlen J
    Virchows Arch; 2015 Aug; 467(2):225-35. PubMed ID: 25898889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the genetics of Alzheimer's disease.
    Levy-Lahad E; Tsuang D; Bird TD
    J Geriatr Psychiatry Neurol; 1998; 11(2):42-54. PubMed ID: 9877525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease families with amyloid precursor protein mutations.
    Rossor MN; Newman S; Frackowiak RS; Lantos P; Kennedy AM
    Ann N Y Acad Sci; 1993 Sep; 695():198-202. PubMed ID: 8239283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenetic factors of Alzheimer disease].
    Bauer J; Hüll M; Berger M
    Z Gerontol Geriatr; 1995; 28(3):155. PubMed ID: 7664189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease.
    Minthon L; Hesse C; Sjögren M; Englund E; Gustafson L; Blennow K
    Neurosci Lett; 1997 Apr; 226(1):65-7. PubMed ID: 9153643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
    Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
    Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.